TY - CHAP M1 - Book, Section TI - Malignancies of the Small Intestine A1 - Ursem, Carling A1 - McQuaid, Kenneth R. A2 - Papadakis, Maxine A. A2 - McPhee, Stephen J. A2 - Rabow, Michael W. A2 - McQuaid, Kenneth R. PY - 2023 T2 - Current Medical Diagnosis & Treatment 2023 AB - Key Clinical Updates in Malignancies of the Small IntestineFor advanced/unresectable disease, first-line doublet chemotherapy is standard. Two trials suggest value from adding bevacizumab to chemotherapy. Pembrolizumab is an accepted treatment modality for mismatch repair-deficient tumors.National Comprehensive Cancer Network. https://www.nccn.org/professionals/physician_gls/pdf/small_bowel.pdf SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/29 UR - accessmedicine.mhmedical.com/content.aspx?aid=1193162414 ER -